You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Common Killing Mechanism for Bactericidal Antibacterial Compounds

Rosenthal, Kenneth S. PhD*; Risley, Kim M. PhD

Infectious Diseases in Clinical Practice:
doi: 10.1097/IPC.0b013e318279f1ac
Immunology/Microbiology for ID
Abstract

Abstract: Recent findings identify a common toxic mechanism for drugs within 3 bactericidal antimicrobial families, β-lactams, quinolones, and aminoglycosides, beyond the primary target interaction. In vitro studies show that treatment with these compounds blocks cell division, which promotes a buildup of reduced nicotinamide adenine dinucleotide, and its oxidation promotes the production of reactive oxygen species, including hydroxyl radicals. The hydroxyl radical oxidizes guanine to 8-deoxy-guanine. 8-deoxy-guanine can base pair with both deoxycytosine and deoxyadenosine, and this mismatch promotes mutation. The cell’s effort to repair closely spaced mismatches with 8-deoxy-guanine causes double-strand breaks in the DNA, which kill the bacteria. These findings identify a common killing mechanism for bactericidal drugs and suggest mechanisms that contribute to the intrinsic susceptibility of bacteria to these drugs.

Author Information

From the *Department of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH and †Department of Biology, University of Mount Union, Alliance, OH.

Correspondence to: Kenneth S. Rosenthal, PhD, Department of Integrative Medical Sciences, Northeast Ohio Medical University, 4209 SR 44, Rootstown, OH 44272. E-mail: ksr@neomed.edu.

The authors have no funding or conflicts of interest to disclose.

© 2013 Lippincott Williams & Wilkins, Inc.